Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms
Rachel K. Surowiec, Rosario Saldivar, Ratan Kumar, Corinne E. Metzger, Andrea M. Jacobson, Matthew R. Allen, Joseph M. Wallace
Topics & Concepts
RaloxifeneEx vivoOsteoporosisMedicineKidney diseaseIn vivoCortical boneEndocrinologyCalcitoninBone mineralInternal medicineUrologyChemistryPathologyBiologyEstrogen receptorBiotechnologyBreast cancerCancerBone health and osteoporosis researchBone Metabolism and DiseasesBone health and treatments